ONC Q1 2023 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q1 2023 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$448M+46.0% YoY

Gross Profit

$366M81.7% margin

Operating Income

-$371M-82.9% margin

Net Income

-$348M-77.8% margin

EPS (Diluted)

$-3.38

QoQ Revenue Growth

+17.8%

Cash Flow

Operating Cash Flow

-$564M

Free Cash Flow

-$689M

Stock-Based Comp.

$75M

Balance Sheet

Total Assets

$6.0B

Total Liabilities

$1.8B

Stockholders' Equity

$4.2B

Cash & Equivalents

$3.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$448M	$307M	+46.0%
Gross Profit	$366M	$241M	+51.6%
Operating Income	-$371M	-$443M	+16.2%
Net Income	-$348M	-$435M	+19.9%